HEALTH CARE SECTOR

 » 

BIOTECHNOLOGY INDUSTRY

 » 

RGO

regeneron pharmaceuticals (RGO:Munich)

Last €196.92 EUR
Change Today -0.08 / -0.04%
Volume 9.0
RGO On Other Exchanges
Symbol
Exchange
REGN:US
NASDAQ GS
RGO:GR
Munich
As of 2:39 AM 05/24/13 All times are local (Market data is delayed by at least 15 minutes).
Financial StatementsRatiosPensions & OptionsSEC Filings

Pension Plan for regeneron pharmaceuticals (RGO)

Shares for Stock Options
-- Million
Common Shares for Exercise
For the fiscal year 2012 in U.S. Dollars
Projected Benefit Obligation--
Accumulative Benefit Obligation--
Total Pension Assets--
Def. Benefit Service Cost--
Def. Benefit Plan Interest Cost--
Def. Benefit Plan Return On Assets--
Def. Benefit Plan Other Cost--
Def. Benefit Plan Total Cost--
Def. Contribution Plan Cost6.30
Total Pension Expense6.30
Exp. Ret. on Pension Assets--
Discount Rate on Obligation--
Assumed Comp. Growth Rate--
Other Post-Retire Benefits Exp.--
Other Benefits Obligation--

Stock Options for regeneron pharmaceuticals (RGO)

Outstanding at Beginning of Year22.33
Issued During the Year4.16
Exercised During the Year5.47
Canceled During the Year0.23
Outstanding at the End of Year20.79
W/Avg. Exercise Price of Options Granted167.96
W/Avg. Exercise Price of Options Outstanding56.03
Report Data IssueReport Data Issue
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
RGO:GR €196.92 EUR -0.08

RGO Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Alkermes PLC $33.00 USD +1.25
Allergan Inc/United States $97.96 USD +0.23
BioMarin Pharmaceutical Inc $65.76 USD +0.21
Onyx Pharmaceuticals Inc $96.20 USD +3.17
Vertex Pharmaceuticals Inc $78.48 USD +0.05
View Industry Companies
 

Industry Analysis

RGO

Industry Average

Valuation RGO Industry Range
Price/Earnings 35.9x
Price/Sales 15.9x
Price/Book 17.9x
Price/Cash Flow 30.4x
TEV/Sales 15.6x
View Detailed RGO Financials
 | 
View Sector Analysis

Post a JobJobs

View all jobs

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact REGENERON PHARMACEUTICALS, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.

Close